Skip to main content

Table 1 Clinical studies of the protective effects of VAs

From: Comparison of volatile anesthetic-induced preconditioning in cardiac and cerebral system: molecular mechanisms and clinical aspects

 

Surgery

Patients and number (n)

Volatile anesthetics and dose

Outcome

Refs.

Cardioprotection

Cardiopulmonary bypass

n = 200

Sevoflurane

0.5–2%

Increase of troponin I ↓

Cardiac output ↑

Inotropic support ↓

Duration of stay in the ICU and hospital ↓

De Hert et al. [79]

Cardiopulmonary bypass

Elderly high-riska patients, n = 45

Sevoflurane

0.5–2%

Desflurane

1–4%

Decrease in cardiac index (CI) post-CPB ↓

Inotropic support ↓

De Hert et al. [80]

Off-pump coronary artery bypass grafting

n = 48

Sevoflurane

1.0 MAC and 1.5 MAC

Post-surgical cardiac Troponin I ↓

Wang et al. [81]

Off-pump coronary artery bypass

n = 45

Isoflurane

1.0–2.5%

Post-surgical cardiac index ↑

Increase of troponin T ↓

Tempe et al. [83]

Off-pump coronary artery bypass

n = 60

Sevoflurane

0.7 and 1 MAC

Increase of troponin I ↓

Postoperative NT-proBNPb ↓

Inotropic support ↓

Guerrero Orriach et al. [84]

On-pump coronary artery bypass

n = 45

Isoflurane 2.5%

10 minc

Hemodynamic recovery ↑

Cardiac troponin T ↓

CK-MB release ↓

Inotropic support ↓

Amr et al. [85]

Cerebral protection

Cardiopulmonary bypass

n = 128

Sevoflurane

0.6–1 MAC

Cognitive function ↑

Schoen et al. [91]

Cardiopulmonary bypass

n = 92

Sevoflurane

0.5 MAC

Isoflurane

0.5 MAC

Postoperative Mg disorders ↓

Increase in plasma MMP-9 and GFAPd concentration ↓

Dabrowski et al. [92]

  1. CPB cardiopulmonary bypass, MAC minimal alveolar concentration
  2. aElderly high-risk: older than 70 years with three-vessel disease and an ejection fraction less than 50% with impaired length-dependent regulation of myocardial function
  3. bN-terminal pro-brain natriuretic peptide
  4. cPreconditioning with a 10-min exposure to isoflurane 2.5% followed by 5-min washout
  5. dSensitive marker of brain injury: matrix metalloproteinase-9 (MMP-9), glial fibrillary acidic protein (GFAP)